Cambridge Investment Research Advisors Inc. boosted its holdings in Amdocs Limited (NASDAQ:DOX – Get Rating) by 19.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 7,616 shares of the technology company’s stock after buying an additional 1,217 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Amdocs were worth $692,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the business. Tempus Wealth Planning LLC raised its stake in shares of Amdocs by 4.8% during the third quarter. Tempus Wealth Planning LLC now owns 2,726 shares of the technology company’s stock valued at $217,000 after purchasing an additional 125 shares during the period. Commonwealth Equity Services LLC raised its stake in shares of Amdocs by 4.9% during the fourth quarter. Commonwealth Equity Services LLC now owns 2,719 shares of the technology company’s stock valued at $247,000 after purchasing an additional 127 shares during the period. D.A. Davidson & CO. raised its stake in shares of Amdocs by 3.3% during the third quarter. D.A. Davidson & CO. now owns 4,147 shares of the technology company’s stock valued at $329,000 after purchasing an additional 134 shares during the period. CENTRAL TRUST Co raised its stake in shares of Amdocs by 3.9% during the fourth quarter. CENTRAL TRUST Co now owns 3,637 shares of the technology company’s stock valued at $331,000 after purchasing an additional 137 shares during the period. Finally, Macquarie Group Ltd. raised its stake in shares of Amdocs by 0.5% during the third quarter. Macquarie Group Ltd. now owns 31,548 shares of the technology company’s stock valued at $2,507,000 after purchasing an additional 148 shares during the period. Hedge funds and other institutional investors own 88.11% of the company’s stock.
Amdocs Trading Down 0.5 %
Shares of DOX opened at $94.55 on Tuesday. The business’s 50-day moving average price is $93.01 and its 200 day moving average price is $90.89. The stock has a market capitalization of $11.42 billion, a P/E ratio of 21.54, a P/E/G ratio of 1.63 and a beta of 0.66. Amdocs Limited has a 1-year low of $76.79 and a 1-year high of $97.08. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21.
Amdocs Dividend Announcement
Analyst Upgrades and Downgrades
DOX has been the topic of a number of analyst reports. Robert W. Baird lifted their price objective on shares of Amdocs from $85.00 to $100.00 and gave the company a “neutral” rating in a research note on Thursday, February 2nd. Barclays raised shares of Amdocs from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $100.00 to $115.00 in a research report on Tuesday, May 16th. Oppenheimer raised their price target on shares of Amdocs from $94.00 to $99.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 1st. 888 reissued a “reiterates” rating on shares of Amdocs in a research report on Thursday, May 11th. Finally, StockNews.com initiated coverage on shares of Amdocs in a research report on Thursday, May 18th. They set a “buy” rating for the company. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $102.50.
Amdocs Company Profile
Amdocs Ltd. is a holding company, which engages in the provision of software products and services for the communications, entertainment, and media industry service providers. The company was founded in 1988 and is headquartered in Saint Louis, MO.
- Get a free copy of the StockNews.com research report on Amdocs (DOX)
- monday.com Surges on Price and Volume after Blowout Results
- Can Ryanair Stock Fly Above Resistance Levels, What Earnings Show
- All Aboard! The Sell-Side Has Railroads In Reversal
- Is There Value Left in Lyft Stock?
- Everything About ZIM Integrated Screams Undervaluation
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.